Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy.
about
Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumorsTargeting cancer using cholesterol conjugatesFolate Functionalized Boron Nitride Nanotubes and their Selective Uptake by Glioblastoma Multiforme Cells: Implications for their Use as Boron Carriers in Clinical Boron Neutron Capture Therapy.MRI-guided neutron capture therapy by use of a dual gadolinium/boron agent targeted at tumour cells through upregulated low-density lipoprotein transporters.Cationized gelatin-HVJ envelope with sodium borocaptate improved the BNCT efficacy for liver tumors in vivoSynthesis and evaluation of a novel ligand for folate-mediated targeting liposomesTumour and dendrimers: a review on drug delivery aspects.Synthesis of α-carboranyl-α-acyloxy-amides as potential BNCT agents.The use of convection-enhanced delivery with liposomal toxins in neurooncology.Applications and perspectives of boron-enriched nanocomposites in cancer therapy.Nanoscaled boron-containing delivery systems and therapeutic agents for cancer treatment.Carborane-layered double hydroxide nanohybrids for potential targeted- and magnetically targeted-BNCT applications.Synthesis of a carborane-containing cholesterol derivative and evaluation as a potential dual agent for MRI/BNCT applications.A carborane-derivative "click" reaction under heterogeneous conditions for the synthesis of a promising lipophilic MRI/GdBNCT agent.Synthesis of cetuximab-immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFR.An Assessment of the Potential Use of BNNTs for Boron Neutron Capture Therapy.Folic acid-conjugated 4-amino-phenylboronate, a boron-containing compound designed for boron neutron capture therapy, is an unexpected agonist for human neutrophils and platelets.The hydroboration reaction as a key for a straightforward synthesis of new MRI-NCT agentsBoron Drug Delivery via Encapsulated Magnetic Nanocomposites: A New Approach for BNCT in Cancer Treatment
P2860
Q24658232-16C74FEF-0117-4337-808D-59996258F027Q26860103-E7922050-BF39-4AE3-887E-4C6C392AC3DFQ33947924-9268FAAE-9F00-4F64-82BF-72E08AC4764EQ34192364-10842849-35FE-45E3-8FD3-74F5873C7E29Q34560282-98674F69-3BA3-4302-AA5B-B59ABB2A5A42Q36713632-ED699959-30A6-4CE7-9686-12B1031D55C8Q37171165-BB4DC0AA-DAE3-4198-88F2-14817E8F80CFQ37384910-9CA3AEC1-AD87-4F73-8448-4FF2EE26198FQ37954331-6D41C09B-C127-43B0-B461-9BEF50DD213BQ38101624-5600F714-8F76-43D0-8742-A104E18058B3Q38451910-8E6EFB7C-E821-4949-BC38-0ACCA9643613Q38948517-CC7B524E-54F6-4F74-A2A8-6607B5BC3B75Q39017790-0E01BF0B-C6B8-4B99-BCBD-906CBC20E4B5Q39244143-9514AD6B-9597-4C77-B38A-DE3AAA42EC96Q40182679-C2471380-4C62-4681-95C5-3C9D1DB8A0D3Q42050106-505AA2F7-5A86-42ED-8F3D-1446F7174804Q50475877-D1DD1C4C-C3AC-47CD-9589-7D97A98B4E0BQ58304723-90B92437-9FFE-44F6-A633-CB45737BBBE4Q58652117-1DE758EB-24C6-410F-BE1D-228F950306AC
P2860
Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Boron containing macromolecule ...... s for neutron capture therapy.
@ast
Boron containing macromolecule ...... s for neutron capture therapy.
@en
type
label
Boron containing macromolecule ...... s for neutron capture therapy.
@ast
Boron containing macromolecule ...... s for neutron capture therapy.
@en
prefLabel
Boron containing macromolecule ...... s for neutron capture therapy.
@ast
Boron containing macromolecule ...... s for neutron capture therapy.
@en
P2093
P1476
Boron containing macromolecule ...... s for neutron capture therapy.
@en
P2093
Joseph M Backer
Marina V Backer
Robert J Lee
Rolf F Barth
Weilian Yang
Werner Tjarks
P304
P356
10.2174/187152006776119153
P577
2006-03-01T00:00:00Z